Adherence to highly active antiretroviral therapy impact on clinical and economic outcomes for Medicaid enrollees with human immunodeficiency virus and hepatitis C coinfection

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 27, Issue 7, 2015, Pages 829-835

  Zhang, Shun ^a   Rust, George ^a   Cardarelli, Kathryn ^b   Felizzola, Jesus ^c   Fransua, Mesfin ^a   Stringer, Harold G ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

adherence; antiretroviral therapy; hepatitis C coinfection; HIV; Medicaid; outcomes

Indexed keywords

ABACAVIR; DARUNAVIR; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; ENFUVIRTIDE; ETRAVIRINE; FOSAMPRENAVIR; HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR; INDINAVIR; LAMIVUDINE PLUS STAVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; RALTEGRAVIR; RITONAVIR PLUS SAQUINAVIR; TENOFOVIR; TIPRANAVIR; ZIDOVUDINE; ANTIVIRUS AGENT;

ADULT; ADVERSE OUTCOME; ARTICLE; CAUSE OF DEATH; CLINICAL ASSESSMENT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DRUG COST; EMERGENCY WARD; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH DISPARITY; HEALTH ECONOMICS; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAID; MIXED INFECTION; MORTALITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; COINFECTION; EPIDEMIOLOGY; HEALTH CARE DELIVERY; HIV INFECTIONS; MEDICATION COMPLIANCE; MIDDLE AGED; PSYCHOLOGY; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; COINFECTION; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MEDICAID; MEDICATION ADHERENCE; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84928609997     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540121.2015.1021745     Document Type: Article

References (17)

1. Buchanan, A. L., Montepiedra, G., Sirois, P. A., Kammerer, B., Garvie, P. A., Storm, D. S., & Nichols, S. L. (2012). Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report. Pediatrics, 129, e1244-e1251. doi: 10.1542/peds.2011-1740
2. CDC. (2013). HIV and viral hepatitis fast fact. Retrieved November 20, 2013, from http://www.cdc.gov/hepatitis/Populations/PDFs/HIVandHep-FactSheet.pdf
3. Chesney, M. (2003). Adherence to HAART regimens. AIDS Patient Care and STDs, 17, 169-177. doi: 10.1089/108729103321619773
4. Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B.,. Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care, 12, 255-266. doi: 10.1080/09540120050042891
5. Godin, G., Côté, J., Naccache, H., Lambert, L. D., & Trottier, S. (2005). Prediction of adherence to antiretroviral therapy: A one-year longitudinal study. AIDS Care, 17, 493-504. doi: 10.1080/09540120412331291715
6. Kiertiburanakul, S., & Sungkanuparph, S. (2009). Emerging of HIV drug resistance: Epidemiology, diagnosis, treatment and prevention. Current HIV Research, 7, 273-278.
7. Kitahata, M. M., Koepsell, T. D., Deyo, R. A., Maxwell, C. L., Dodge, W. T., & Wagner, E. H. (1996). Physicians experience with the acquired immunodeficiency syndrome as a factor in patients survival. New England Journal of Medicine, 334, 701-707.
8. Mellins, C. A., Havens, J. F., McDonnell, C., Lichtenstein, C., Uldall, K., Chesney, M., Bell, J. (2009). Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders. AIDS Care, 21, 168-177.
9. Moatti, J. P., Carrieri, M. P., Spire, B., Gastaut, J. A., Cassuto, J. P., Moreau, J., & Manif 2000 Study Group. (2000). Adherence to HAART in French HIV-infected injecting drug users: The contribution of buprenorphine drug maintenance treatment. AIDS, 14, 151-155. doi: 10.1097/00002030-200001280-00010
10. Moss, A. R., Hahn, J. A., Perry, S., Charlebois, E. D., Guzman, D., Clark, R. A., & Bangsberg, D. R. (2004). Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: A prospective study. Clinical Infectious Diseases, 39, 1190-1198. doi: 10.1086/424008
11. Schneider, E., Whitmore, S., Glynn, K. M., Dominguez, K., Mitsch, A., & McKenna, M. T. (2008). Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years, United States, 2008. MMWR Recommendations and Reports, 57 (10), 1-12.
12. Sherman, K. E., Rouster, S. D., Chung, R. T., & Rajicic, N. (2002). Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clinical Infectious Diseases, 34, 831-837. doi: 10.1086/339042
13. Simoni, J. M., Kurth, A. E., Pearson, C. R., Pantalone, D. W., Merrill, J. O., & Frick, P. A. (2006). Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS and Behavior, 10, 227-245. doi: 10.1007/s10461-006-9078-6
14. Soriano, V., Sulkowski, M., Bergin, C., Hatzakis, A., Cacoub, P., Katlama, C., Rockstroh, J. (2002). Care of patients with chronic hepatitis C and HIV co-infection: Recommendations from the HIV-HCV International Panel. AIDS, 16, 813-828. doi: 10.1097/00002030-200204120-00001
15. Starr, W. M., & Springer, L. B. (2014). CE: Nursing in the fourth decade of the HIV epidemic. American Journal of Nursing, 114 (3), 38-47. doi: 10.1097/01.NAJ.0000444491.93733.53
16. Tu, D., Belda, P., Littlejohn, D., Pedersen, J. S., Valle-Rivera, J., & Tyndall, M. (2013). Adoption of the chronic care model to improve HIV care: In a marginalized, largely aboriginal population. Canadian Family Physician, 59, 650-657.
17. Wolfe, D., Carrieri, M. P., & Shepard, D. (2010). Treatment and care for injecting drug users with HIV infection: A review of barriers and ways forward. The Lancet, 376, 355-366. doi: 10.1016/S0140-6736(10)60832-X